HOME >> MEDICINE >> NEWS
Experts to address use of patient-reported outcomes in clinical trials at joint Mayo-FDA forum

Dozens of medical research experts will assemble Feb. 23-25, 2006, in Chantilly, Va., to discuss how patient-reported outcomes (PROs) should be developed, validated, interpreted and used in clinical trials. This symposium, jointly sponsored by Mayo Clinic and the U.S. Food and Drug Administration (FDA), is a forum for discussion and feedback regarding the soon-to-be-released FDA draft guidance for industry on using PRO measures to support medical product labeling claims. The draft guidance will be published in the Federal Register with an invitation for public comment.

"Exactly how we incorporate patient-reported outcomes into cancer research has been murky for a long time. It is a great opportunity to bring clarity and consensus to the issue," says Jan Buckner, M.D., Mayo Clinic medical oncologist and chair of the North Central Cancer Treatment Group (NCCTG). The group specializes in researching methods of treating and preventing cancer, as well as methods to alleviate the side effects of cancer and cancer treatments. "Clinicians and researchers around the world are going to be able to use the information presented at this symposium as a guide for how and when to use patient-reported outcomes. It's really a step forward for all of us."

Five writing teams composed of experts in PRO research will present papers on the major themes covered in the draft guidance: conceptual issues; PRO instrument selection; PRO instrument development issues; validation of PROs; and analysis, interpretation and reporting results based on PROs. Each document will include recommendations on the most appropriate methods of how PROs should be incorporated into clinical trials, and will advocate additional research needed to overcome limitations currently faced in the application of PROs. Attendees will have the opportunity to discuss and comment on these papers as well as the FDA's draft guidance.

FDA's experts in PRO measurement in clinical trials also wil
'"/>

Contact: Elizabeth Zimmermann
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
25-Jan-2006


Page: 1 2

Related medicine news :

1. Experts predict Tamiflu could halve the pandemic influenza death toll versus no intervention
2. Experts call for urgent research into anti-epileptic drugs given to children
3. Experts debate role of stenting, bypass surgery in left main coronary artery disease
4. Medicalize me: Experts look at how our perceptions of illness are shaped
5. Experts urge strongest isolation for new drug-resistant tuberculosis cases appearing in South Africa
6. Experts add to growing warnings about asthma drug
7. Experts review current and future approaches to dementia diagnosis
8. Experts present strategies to address adolescent violence and bullying
9. Experts call for balance in addressing under treated pain and drug abuse
10. Experts question prevalent stereotypes about autism
11. Experts call for re-focussing of COPD management to reduce hospital admissions and mortality

Post Your Comments:
(Date:4/21/2015)... 2015 Invictus Medical has secured ... university for a second innovative technology aimed at ... to newborn infants’ cognitive development. , “This technology ... we have identified through extensive interviews and input ... Hutchinson, Invictus Medical’s Chief Technology Officer. “We believe ...
(Date:4/20/2015)... Heritage Woods of Centralia, a Gardant affordable assisted ... Spaghetti Dinner from 4 p.m. to 6 p.m. on ... Centralia, Illinois, houses senior living apartments, affordable assisted living ... older. , Guests are invited to tour the community ... seniors. After the tours, they can take home spaghetti ...
(Date:4/20/2015)... (PRWEB) April 21, 2015 Reality show ... and girlfriends at the twentieth annual Michigan International Women’s ... in Novi. , “There is lots to see and ... to shopping for fashion and gifts,” said Beth Anderson, ... are entertaining and encouraging with appearances from Randy Fenoli ...
(Date:4/20/2015)... The partners of Urgent Care of Westchester and Riverdale ... Med Spa with a special event. Residents of Westchester County ... p.m. on April 24 on 909 Midland Ave. in Yonkers, ... will also get the chance to win free services from ... purchase, as well as up to 40 percent discounts on ...
(Date:4/20/2015)... The American Association for Physician Leadership® ... Improvement as the 2015 winner of the Leape Ahead ... Meeting, April 18, in Las Vegas, Nevada. , ... safety can be dramatically improved,” said Peter Angood, MD, ... Medicine and its Academy for Quality and Safety should ...
Breaking Medicine News(10 mins):Health News:Invictus Medical Secures Rights to Second Promising New NICU Technology 2Health News:Heritage Woods of Centralia Senior Living Community to Host Open House and Spaghetti Dinner 2Health News:Perfect Girls Day Out at Michigan International Women’s Show Opening Thursday, April 30 in Novi Presented by Southern Shows 2Health News:Perfect Girls Day Out at Michigan International Women’s Show Opening Thursday, April 30 in Novi Presented by Southern Shows 3Health News:Bella Diosa Says Hello to Yonkers Community with Spa Party 2Health News:2015 Leape Ahead Award honors Northwestern Medicine’s Academy for Quality and Safety Improvement 2Health News:2015 Leape Ahead Award honors Northwestern Medicine’s Academy for Quality and Safety Improvement 3
(Date:4/20/2015)... Calif. , April 20, 2015  Published ... positive trends in the ability of Neuraltus ... progression of amyotrophic lateral sclerosis (ALS, also known ... 6-month treatment period. While NP001,s slowing of decline ... study was not statistically significant, clinically meaningful slowing ...
(Date:4/20/2015)... April 20, 2015  OpGen, Inc., a molecular ... of its executive management team with the appointments ... executive Kevin Krenitsky , M.D. as president, ... chief financial officer. With more ... global diagnostic and biotechnology operations, including senior commercial ...
(Date:4/20/2015)... , April 20, 2015 ... disease and specifically autism drug candidates, a few viable ... such as fragile X syndrome.   Biotech Companies in ... (NASDAQ: CYTR ), Trovagene, Inc., (NASDAQ: TROV ... Laboratories (NYSE: ABT ) & Lexicon Pharmaceuticals, Inc. ...
Breaking Medicine Technology:Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 2Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 3Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 4Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 5OpGen Appoints Industry Veterans Dr. Kevin Krenitsky as President and Timothy Dec as Interim Chief Financial Officer 2OpGen Appoints Industry Veterans Dr. Kevin Krenitsky as President and Timothy Dec as Interim Chief Financial Officer 3OpGen Appoints Industry Veterans Dr. Kevin Krenitsky as President and Timothy Dec as Interim Chief Financial Officer 4Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research 2Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research 3Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research 4Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research 5Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research 6
Cached News: